Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_14-cv-02946/USCOURTS-cand-3_14-cv-02946-5/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 28:1331 Fed. Question

---

ORDER (No.14-cv-02946-LB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

San Francisco Division

TRIREME MEDICAL, LLC,

Plaintiff,

v.

ANGIOSCORE, INC.,

Defendant.

Case No. 14-cv-02946-LB 

ORDER 

ON CLAIM CONSTRUCTION

[ECF No. 99]

ORDER

The court hereby adopts the parties’ agreed claim construction that is set out in ECF No. 99. 

See Patent L.R. 4-3. The parties state that they have no claim-construction disputes. (ECF No. 99 

at 3; ECF No. 101 at 2 [¶ 17].) The court acknowledges the parties’ identification of the terms in 

ECF No. 99 as “the most significant to the resolution of [this] case.” See (ECF No. 99 at 3); Patent 

L.R. 4-3(c). The court accepts the parties’ joint proposal (ECF No. 99 at 2 [¶ 17]) to remove from 

the calendar the previously scheduled claim-construction briefs and Markman hearing.

IT IS SO ORDERED.

Dated: August 2, 2016

______________________________________

LAUREL BEELER

United States Magistrate Judge

Case 3:14-cv-02946-LB Document 102 Filed 08/02/16 Page 1 of 1